Intelligence Platform
Patents
Browse 3,720 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 6528097
Sustained release non-steroidal, anti-inflammatory and lidocaine PLGA microspheres
expired patentUS 6528065
Attenuated dengue-3 virus vaccine
expired patentUS 6524590
Identification of a new ehrlichia species from a patient suffering from ehrlichiosis
expired patentUS 6521635
Inhibition of MXR transport by acridine derivatives
expired patentUS 6521229
41 kDa Cryptosporidium parvum oocyst wall protein
expired patentUS 6521212
Method for treating peripheral vascular disease by administering benzindene prostaglandins
expired patentUS 6518061
IL-13 receptor specific chimeric proteins and uses thereof
expired patentUS 6517842
Marburg virus vaccines
expired patentUS 6514501
Recombinant vaccine against dengue virus
expired patentUS 6511991
Nitric oxide-releasing amidine- and enamine-derived diazeniumdiolates, compositions and us
expired patentUS 6511667
Attenuated dengue-2 virus vaccine
expired patentUS 6509344
Indenoisoquinolines as antineoplastic agents
expired patentUS 6506885
Monoclonal antibodies to the drug tilmicosin and a method for detecting the same
expired patentUS 6500859
Method for treating atherosclerosis or restenosis using microtubule stabilizing agent
expired patentUS 6500433
Polypeptide fragments capable of competition with Streptococcus mutans antigen I/II
expired patentUS 6497884
Chimeric vaccine against tick-borne encephalitis virus
expired patentUS 6495145
LktA deletion mutant of P. haemolytica
expired patentUS 6495143
Botulinum neurotoxin vaccine
expired patentUS 6492166
Use of constitutive transport elements for host range control
expired patentUS 6492165
Retrovirus isolated from humans
expired patentUS 6491908
Selective elimination of T cells that recognize specific preselected targets
expired patentUS 6482415
Expression and refolding of truncated recombinant major outer membrane protein antigen (r5
expired patentUS 6479465
Methods of treating colitis using STAT-4 anti-sense oligonucleotides
expired patentUS 6479286
Methods and compositions for making dendritic cells from expanded populations of monocytes
expired